| 12318389 |
Formulations of an AXL/MER inhibitor |
Francis X. Muller |
2025-06-03 |
| 11918585 |
Formulations of an AXL/MER inhibitor |
Francis X. Muller |
2024-03-05 |
| 11241438 |
Formulations of an AXL/MER inhibitor |
Francis X. Muller |
2022-02-08 |
| 10166221 |
Formulations of an LSD1 inhibitor |
Ying Liu, Mei Li, Tanvi Shah, Huifang Wu |
2019-01-01 |
| 7713548 |
Amorphous solid dispersions |
Irwin C. Jacobs, John D. Higgins, III, Micael Guillot, Nancy M. Franson, Khawla Abu-Izza |
2010-05-11 |
| 7683062 |
Crystalline form |
John D. Higgins, III |
2010-03-23 |
| 6197787 |
Pharmaceutical formulations containing poorly soluble drug substances |
Nancy M. Franson, Micael Guillot, Sharon M. Laughlin |
2001-03-06 |
| 5837714 |
Solid pharmaceutical dispersions |
Sharon M. Laughlin |
1998-11-17 |
| 5776987 |
Pharmaceutical suspension formulation |
Sharon M. Laughlin |
1998-07-07 |
| 5656288 |
Stable pharmaceutical compositions containing tiludronate hydrates and process for producing the pharmaceutical compositions |
Sharon M. Laughlin |
1997-08-12 |